Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in Ph+ Leukemia
NCT00511069Phase 2Completed
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- Jul 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), sponsored by Alma Mater Studiorum – Università di Bologna. Started Jul 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
chronic myeloid leukemia (CML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00511069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511069.